foxo4 dri senolytic 2023 2024 CHK2-USP37 axis stabilizes to sustain senescence and evade apoptosis FOXO4-DRI part 1 #peptide #molecule

United Healthcare covers GLP-1 medications for eligible members in 2026, but coverage varies by plan type, medical necessity, and prior authorization requirements

CagriSema represents the parallel combination-approach frontier, in advanced Phase 3 trials

Zilbrysq won approval based on the Phase III RAISE study, which assessed the therapy in adults with anti-acetylcholine receptor antibody-positive gMG

Brian Lamkin, the leading functional medicine doctor in Oklahoma and founder of The Lamkin Clinic in Edmond, has been at the forefront of peptide therapy since establishing his practice in 2007

This is one statistic that we should not ignore. Join the SSRP and the Alzheimers Foundation of America @alzfdn in the fight to finally #CancelAlzheimers Tap the link below for more info on this event and how to donate and support Alzheimer's research. Link: #alzheimers #dementiasupport #dementia #alzfdn #alzheimersawareness #prevention #cellefficiency #regenerativemedicine #antiaging #healthyaging #ssrp #ssrpinstitute #seeds4health #drseedshealth #williamseedsmd #seedsmd Dr

Current COAs are posted on our Certifications page